Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BCBA/MRK stock hub

BCBA/MRK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/MRKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

383.1T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/MRK

In the news

Latest news · BCBA/MRK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.9

P25 14.1P50 17.9P75 19.4

Trailing P/E31

P25 25P50 30P75 39

ROE18.9

P25 6.8P50 15.6P75 45.1

ROIC21.2

P25 9P50 19.1P75 21.2

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/MRK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	74,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	ARS 443.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US58933Y1055
Last refreshed	2026-05-10
Market cap	ARS 383.1T
Price	ARS 33,060
Price currency	ARS
Rev Per Employee	1,227,829,635.43x
Sector	Healthcare
Sic	2834
Symbol	bcba/MRK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.22%
EV Earnings	35.94x
EV/EBIT	12.98x
EV/EBITDA	10.64x
EV/FCF	22.75x
EV/Sales	4.84x
FCF yield	5.09%
Forward P/E	17.9x
P/B ratio	6.04x
P/E ratio	31.04x
P/S ratio	4.22x
PE Ratio10 Y	54.31x
PE Ratio3 Y	99.8x
PE Ratio5 Y	67.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	37.3%
EBITDA Margin	44.88%
FCF margin	21.46%
Gross margin	76.73%
Gross Profit	ARS 69.7T
Gross Profit Growth	2.43%
Gross Profit Growth Q	2.18%
Gross Profit Growth3 Y	6.22%
Gross Profit Growth5 Y	10.9%
Net Income	ARS 12.3T
Net Income Growth	-48.75%
Net Income Growth3 Y	-11.82%
Net Income Growth5 Y	4.92%
Pretax Margin	17.68%
Profit Margin	13.59%
Profit Per Employee	ARS 166.8M
ROA	12.58
Roa5y	11.18
ROCE	24.11
ROE	18.94
Roe5y	30.37
ROIC	21.18
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	88.91%
Cagr15y	70.58%
Cagr1y	84.03%
Cagr20y	53.41%
Cagr3y	48.11%
Cagr5y	74.44%
Div CAGR10	85.53%
Div CAGR3	108.37%
Div CAGR5	88.5%
EPS Growth	-48.02
EPS Growth3 Y	-11.28
EPS Growth5 Y	5.25
FCF Growth	-17.16%
FCF Growth Q	149.74%
FCF Growth3 Y	7.82%
FCF Growth5 Y	16.21%
OCF Growth	-14.31%
OCF Growth Q	56.72%
OCF Growth10 Y	3.71%
OCF Growth3 Y	4.51%
OCF Growth5 Y	9.85%
Revenue Growth	2.89x
Revenue Growth Q	4.88x
Revenue Growth3 Y	4.36x
Revenue Growth5 Y	9.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.54
Assets	ARS 177.8T
Cash	ARS 7.9T
Current Assets	ARS 49T
Current Liabilities	ARS 37.7T
Debt	ARS 67.9T
Debt EBITDA	ARS 1.64
Debt Equity	ARS 1.07
Debt FCF	ARS 3.48
Equity	ARS 63.5T
Interest Coverage	16.11
Liabilities	ARS 114.3T
Long Term Assets	ARS 128.8T
Long Term Liabilities	ARS 76.6T
Net Cash	ARS -60T
Net Cash By Market Cap	ARS -15.66
Net Debt EBITDA	ARS 1.47
Net Debt Equity	ARS 0.95
Net Debt FCF	ARS 3.08
Tangible Book Value	ARS -2T
Tangible Book Value Per Share	ARS -810
WACC	4.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	2.42
Net Working Capital	ARS 6.6T
Quick ratio	0.7
Working Capital	ARS 11.1T
Working Capital Turnover	ARS 9,877

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.79%
Dividend Growth	46.91%
Dividend Growth Years	3%
Dividend per share	ARS 588
Dividend Years	29
Dividend Yield	1.78%
Ex Div Date	2026-03-16
Last Dividend	ARS 152
Payout Frequency	Quarterly
Payout Ratio	92.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	57,732.79%
1Y total return	83.96%
200-day SMA	29,327
3Y total return	225.02%
50-day SMA	34,452
50-day SMA vs 200-day SMA	50over200
5Y total return	1,514.76%
All Time High	38,490
All Time High Change	-14.11%
All Time High Date	2024-07-04
All Time Low	5.74
All Time Low Change	575,858.19%
All Time Low Date	2000-03-06
ATR	815.1
Beta	0.2
Ch YTD	2.42
High	33,840
High52	36,840
High52 Date	2026-02-05
High52ch	-10.26%
Low	33,020
Low52	16,950
Low52 Date	2025-05-14
Low52ch	95.04%
Ma50ch	-4.04%
Price vs 200-day SMA	12.73%
RSI	42.34
RSI Monthly	64.39
RSI Weekly	53.65
Sharpe ratio	1.54x
Sortino ratio	2.62
Total Return	3.57%
Tr YTD	3.14
Tr15y	301,362.01%
Tr1m	-6.35%
Tr1w	-2.25%
Tr3m	-8.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 33.9T
Operating Income Growth	0.5
Operating Income Growth Q	1.06
Operating Income Growth3 Y	7.38
Operating Income Growth5 Y	17.25
Operating margin	37.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,465,769,316%
Net Borrowing	19,298,681,938,766
Shares Insiders	0.05%
Shares Institutions	80%
Shares Qo Q	-0.64%
Shares Yo Y	-1.79%
Short Ratio	2.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 18.4T
Average Volume	2,229.55x
Bv Per Share	25,663.5
CAPEX	ARS -5.2T
Ch10y	43,659.1
Ch15y	209,140.5
Ch1m	-6.35
Ch1w	-2.25
Ch1y	79.43
Ch20y	317,784.6
Ch3m	-9.28
Ch3y	208.7
Ch5y	1,233.3
Ch6m	30.16
Change	-0.6%
Change From Open	-2.3
Close	33,260
Days Gap	1.74
Depreciation Amortization	6,970,911,058,328
Dollar Volume	31,340,880
Earnings Date	2026-04-30
EBIT	ARS 33.9T
EBITDA	ARS 40.8T
EPS	ARS 4,940
F Score	4
FCF	ARS 19.5T
FCF EV Yield	4.4x
Financing CF	1,177,049,672,400
Fiscal Year End	December
Founded	1,891
Goodwill	30,184,436,506,777
Graham Number	11455.62173
Graham Upside	-65.35
Income Tax	ARS 3.7T
Investing CF	-31,034,323,756,800
Is Primary Listing	0
Last Earnings Date	2026-02-03
Last Report Date	2026-03-31
Lynch Fair Value	ARS 5,326
Lynch Upside	-83.89
Ma150	31,594.1
Ma150ch	4.64%
Ma20	33,841
Ma20ch	-2.31%
Net CF	-4,605,966,675,800
Open	33,840
P FCF Ratio	19.65
P OCF Ratio	15.5
Payment Date	2026-04-07
Position In Range	4.88
Ppne	35,572,066,803,061
Price Date	2026-05-08
Price EBITDA	ARS 9.4
Relative Volume	0.43x
Revenue	90,859,393,021,600x
SBC By Revenue	1.23x
Share Based Comp	1,119,026,097,000
Tax By Revenue	4.1x
Tax Rate	23.17%
Tr20y	521,151.98%
Tr6m	31.76%
Volume	948
Z Score	3.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/MRK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$588 annual per share

Payout ratio

+92.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+88.5%

3 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2026-03-16

Performance

BCBA/MRK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/MRK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/MRK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.3

Neutral momentum band

Price vs 200-day MA

+12.7%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

1.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/MRK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/MRK stock rating?

bcba/MRK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/MRK analysis?

The full report lives at /stocks/bcba/MRK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/MRK?

The latest report frames bcba/MRK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/MRK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.